199 related articles for article (PubMed ID: 38055156)
21. Safety of "inert" additives or excipients in paediatric medicines.
Nahata MC
Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F392-3. PubMed ID: 19846397
[No Abstract] [Full Text] [Related]
22. Hospitalised neonates in Estonia commonly receive potentially harmful excipients.
Lass J; Naelapää K; Shah U; Käär R; Varendi H; Turner MA; Lutsar I
BMC Pediatr; 2012 Aug; 12():136. PubMed ID: 22931304
[TBL] [Abstract][Full Text] [Related]
23. Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations.
Thomazini VC; da Cunha GM; Guimarães NM; Saleme SD; de Melo RCG; de Paula GA; Carvalho SG; Chorilli M; Dos Santos Giuberti C; Villanova JCO
Daru; 2024 Jun; 32(1):289-305. PubMed ID: 37903944
[TBL] [Abstract][Full Text] [Related]
24. The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia.
Fister P; Urh S; Karner A; Krzan M; Paro-Panjan D
J Matern Fetal Neonatal Med; 2015; 28(17):2053-61. PubMed ID: 25316561
[TBL] [Abstract][Full Text] [Related]
25. Excipient exposure in very low birth weight preterm neonates.
Akinmboni TO; Davis NL; Falck AJ; Bearer CF; Mooney SM
J Perinatol; 2018 Feb; 38(2):169-174. PubMed ID: 29095430
[TBL] [Abstract][Full Text] [Related]
26. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
Nasrollahi S; Meera NK; Boregowda S
Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
[TBL] [Abstract][Full Text] [Related]
27. Effect of polyols on interaction of paraben preservatives with polysorbate 80.
Blanchard J
J Pharm Sci; 1980 Feb; 69(2):169-73. PubMed ID: 7359317
[TBL] [Abstract][Full Text] [Related]
28. Excipients and additives: hidden hazards in drug products and in product substitution.
Napke E; Stevens DG
Can Med Assoc J; 1984 Dec; 131(12):1449-52. PubMed ID: 6498699
[TBL] [Abstract][Full Text] [Related]
29. Pediatric Safety of Polysorbates in Drug Formulations.
Kriegel C; Festag M; Kishore RSK; Roethlisberger D; Schmitt G
Children (Basel); 2019 Dec; 7(1):. PubMed ID: 31877624
[TBL] [Abstract][Full Text] [Related]
30. Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
Ursino MG; Poluzzi E; Caramella C; De Ponti F
Regul Toxicol Pharmacol; 2011 Jun; 60(1):93-105. PubMed ID: 21354240
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the Local Tolerability to 5 Long-acting Drug Nanosuspensions with Different Stabilizing Excipients, Following a Single Intramuscular Administration in the Rat.
Chamanza R; Darville N; van Heerden M; De Jonghe S
Toxicol Pathol; 2018 Jan; 46(1):85-100. PubMed ID: 29096596
[TBL] [Abstract][Full Text] [Related]
32. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.
Turner MA; Duncan JC; Shah U; Metsvaht T; Varendi H; Nellis G; Lutsar I; Yakkundi S; McElnay JC; Pandya H; Mulla H; Vaconsin P; Storme T; Rieutord A; Nunn AJ
Adv Drug Deliv Rev; 2014 Jun; 73():89-101. PubMed ID: 24239480
[TBL] [Abstract][Full Text] [Related]
33. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
[TBL] [Abstract][Full Text] [Related]
34. The risk of neurodevelopmental disorders following Thimerosal-containing Hib vaccine in comparison to Thimerosal-free Hib vaccine administered from 1995 to 1999 in the United States.
Geier DA; Kern JK; Homme KG; Geier MR
Int J Hyg Environ Health; 2018 May; 221(4):677-683. PubMed ID: 29573974
[TBL] [Abstract][Full Text] [Related]
35. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study.
de Souza AS; Dos Santos DB; Rey LC; Medeiros MG; Vieira MG; Coelho HLL
BMC Pediatr; 2016 Jan; 16():13. PubMed ID: 26795213
[TBL] [Abstract][Full Text] [Related]
36. A case of severe immediate type reaction to macrogol and polysorbate 60 after intravaginal drug application.
Schwede K; Simon JC; Treudler R
Eur J Dermatol; 2019 Jun; 29(3):329-331. PubMed ID: 31389792
[No Abstract] [Full Text] [Related]
37. Final report on the safety assessment of Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate.
Nair B
Int J Toxicol; 2001; 20 Suppl 3():23-50. PubMed ID: 11766131
[TBL] [Abstract][Full Text] [Related]
38. Acute amiodarone toxicity due to an administration error: could excipient be responsible?
Masi S; de Cléty SC; Anslot C; Detaille T
Br J Clin Pharmacol; 2009 Jun; 67(6):691-3. PubMed ID: 19076154
[No Abstract] [Full Text] [Related]
39. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
[TBL] [Abstract][Full Text] [Related]
40. Influence of isotonic agents on the stability of thimerosal in ophthalmic formulations.
Reader MJ
J Pharm Sci; 1984 Jun; 73(6):840-1. PubMed ID: 6429316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
